Startup Europe Awards

blog news

ISCIII launches ‘Covid-19 Fund’ for studies to improve short-term management of Coronavirus

The Carlos III Health Institute (ISCIII), dependent on the Ministry of Science and Innovation, has launched the call for the ‘COVID-19 Fund’ to finance research projects on the SARS-CoV-2 virus and the disease it causes, the Coronavirus. This call will have 24 million Euros, as approved in the Royal Decree-Law 8/2020, last March 17th, of extraordinary urgent measures to face the economic and social impact of the new coronavirus. The aim is to contribute to improving the public health response and to develop new preventive, diagnostic and therapeutic tools. These must be projects that can be implemented immediately in the National Health System (SNS). They will also prioritize concrete results applicable to the current situation.

The areas of research that will be eligible for funding are the development of rapid virological diagnosis techniques for Covid-19, development of vaccines, analysis of their effectiveness and applicability, projects on the clinical, biological and molecular characterisation of the disease, as well as ideas for developing innovative therapies, new antiviral, antiseptic and disinfectant molecules against SARS-CoV-2.

In addition, this call also seeks studies on antiviral resistance and on the effectiveness of non-pharmacological, prophylactic and therapeutic interventions, the characterization of the virus (genetic variation and antigen), the management of the immune response and the virus-host interaction.

On the other hand, the Finnova Foundation, based in Brussels, will advise those interested in this call as it has experts in the presentation of proposals and in addition, we are already invested in several projects related to COVID-19.

Artificial intelligence and integrated mass data analysis
The call will also finance projects on epidemiological surveillance and molecular study of Covid-19, with analysis of mortality, morbidity and lethality incidence; study of environmental and social factors of the spread, risk factors and population dynamics of the infection. Projects using artificial intelligence tools and the massive analysis of integrated data for the epidemiological control of the disease are also eligible for this economic fund, as well as research on the socio-economic impact of the disease: use of primary care resources, general hospital resources and critical care resources.

A specific committee to evaluate all proposals
The evaluation of the projects will be carried out by the Scientific and Technical Committee for the Evaluation of Expressions of Interest for Research Projects in Covid-19 and SARS-COV-2 (CTE-Covid-19), whose coordinator is Cristóbal Belda, ISCIII’s Assistant Director General for Research Evaluation and Promotion and responsible for Strategic Action in Health (SEA), and eight other members. According to the ministry, the Committee will assist in the approach and possible modifications to those presenting projects. Proposals will be submitted by email to, using the template available for download from the ISCIII website.

According to the Ministry of Health, in addition to the 24 million euros, ISCIII has also received another 1.2 million euros, which it will devote in part to its own research projects.

blog news Uncategorized

9th Philanthropic Program of REPSOL Startup Acceleration

  • Energy multinational announces awards to help innovative energy and mobility startups
  • The deadline for submission is March 4

Repsol, the energy multinational, has announced the 9th edition of its philanthropic program for Startup Acceleration to help innovative companies in the pre-commercial phase to bring their technological solutions to the market. The aim is for startups to work on solutions for the energy industry, new mobility and the circular economy, contributing to a sustainable energy transition. The program includes donations of up to 120,000 euros without taking an equity stake or intellectual property.

The deadline for submitting applications to the 9th Philanthropic Programme of REPSOL Startup Acceleration is March 4th.

More information and application forms can be found on the Repsol Foundation website:

blog news

Finnova visits Bioalgae, the winner of the Cop25 Water Startup Europe Awards

Alicante company, which proposes solutions to environmental problems, achieves its internationalization in the market

Finnova Foundation has visited the facilities of Bioalgae, in Crevillente (Alicante), the company that won the COP25 Startup Europe Awards in the water category. The Bioalgae project is based on the development of an efficient production method applicable not only to the production of micro alkaline biomass, but also to propose solutions to environmental problems (wastewater and CO2 capture) and their integration into the real world (urban furniture).

Finnova’s CEO Juan Manuel Revuelta, has attended the company to get to know the company’s facilities first-hand and see how they work. Thanks to the Startup Europe Awards, a Finnova project, the company was able to attract funds from the European Union, international investment and networking for a legal framework linked to the circular economy and climate change.

The added value of Bioalgae is its more than 30 years’ experience of biomass cultivation for industry. The choice of different species, each of them optimal for a specific purpose, has been the result of many years of research and development. Finally, the creation of a reactor model that ensured high productivity with less maintenance has been another achievement. The main pillars of the company’s philosophy are giving a real solution to each problem, permanent innovation, imagination and action, as the final action makes the proposed solution feasible in the real world.

Finnova is the European Foundation that works for the constant commitment to business innovation and excellence of applied knowledge through the development of talent and its international and interregional connection.